EFTA Document EFTA02082955

To: From: Jeffrey E. Sent Wed 3/4/2015 2:47:42 PM Subject Re: Joe Thakuria (again) pull up his last rcpsonse before this one On Wed, Mar 4, 2015 at 3:47 PM,■ Please see below: Begin forwarded message: From: Joseph Thakuria Subject: Re: Jeffrey Epstein Date: March 4 2015 at 9:20:15 AM EST To: wrote: We're also starting a clinical ngs lab that should complete its full certification next month. So if Jeffreys interested, I should be able to continue providing him with other types of genomic data beyond his exome on his samples free of charge. For example, I think I'll be able to quickly follow up on his exome with a whole genome this summer. Basically, once I get through the first pass and our lab is fully set up, adding additional datasets will go much easier. In my opinion, there's no harm (in these early days) with individuals having more than I genomic dataset and analyses. Joe On Mar 4, 2015 9:09 AM, "Joseph Thakuria" clIMI > wrote: Lesley, sorry for the delayed response. We are still in the middle of analyzing our first batch (and no ypo have gotten their results yet). Unfortunately, Jeffrey is in the second run which should be completed by end of this month. (Because his was part of a batch of about 20 that needed DNA re-extracted from saliva and resequenced.) Please apologize for the delay to Jeffrey. On the positive side, the number of medically important genes we will deeply analyze has doubled since he submitted his sample based on the most recent literature. Joe EFTA_R1_00808088 EFTA02082955 On Mar 3, 2015 9:49 AM, > wrote: Hello Joe! Checking in...it's March! do you have any news for Jeffrey? Thanks please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00868089 EFTA02082956